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Abstract ] 
The influence of melanin on the binding of xenobiotics in hair will 
impact the interpretation of drug concentrations determined by 
hair testing. The purpose of this study was to determine if codeine, 
as a model compound of abused drugs, would be incorporated into 
black, brown, blond, or red hair as a function of melanin 
concentration. Such data would assist in the interpretation of 
codeine concentrations i  hair and help elucidate he potential 
influence of hair color on incorporation of drugs. Male and female 
Caucasians with black (n = 6), brown (n = 12), blond (n = 8), or red 
hair (n = 6) and non.Caucasians with black hair (n = 12) aged 
21-40 years were enrolled in the study. Each subject was 
administered oral codeine phosphate syrup in a dosage of 30 mg 
three times a day for five days. Twenty.four hours after the end of 
the treatment period, a 30.rag codeine dose was administered and 
the subject's plasma area under the concentration time curve 
(AUC) for codeine was determined. Codeine and melanin were 
measured in the first 3 cm of hair closest o the vertex region of the 
scalp prior to and 1, 4, 5, 6, and 7 weeks after dosing. The
quantitative and qualitative melanin profiles were determined for 
each subjects hair to provide an objective measure of hair color. 
The plasma concentrations of codeine were measured to eliminate 
differences in the bioavailability and clearance of codeine as 
factors that might account for the differences incodeine hair 
concentrations. The subjects were asked not to cut heir hair in the 
vertex region of the scalp or to use any form of chemical treatment 
on their hair, but otherwise normal hygienic measures were 
permitted. The mean (• SE) hair codeine concentrations 5 weeks 
after dosing were 1429 (+249) pg/mg in black hair; 208 (• 17) 
pg/mg in brown hair; 99 (• 10) pg/mg in blond hair; and 69 (• 11) 
in red hair pg/mg. In black hair, codeine concentrations were 2564 
(• 170) pg/mg for Asians and 865 (• 162) pg/mg for Caucasians. 
Similar concentration relationships were observed at w eks 4, 6, 
and 7. A strong relationship between thehair concentrations of
codeine and melanin (R 2 = 0.73) wasobserved. Normalization of
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the codeine concentration with the melanin concentration 
reduced the hair color differences observed. These data 
demonstrate that the interpretation and reporting of hair test 
results for codeine are influenced by hair color. After this dosing 
protocol, the proposed federal guideline cutoff of 200 pg/mg of 
codeine would result in 100% of subjects with black hair and 
50% of subjects with brown hair being reported as positive, and 
subjects with blond or red hair would be reported as negative. 
The incorporation of these drugs into hair should be studied 
carefully in humans to ensure the appropriate interpretation of 
drug concentrations. 
Introduction 
An effect of hair color on the interpretation of hair tests for 
drugs of abuse would affect the lives of workers, children, stu- 
dents, athletes, and persons in the civil and criminal justice sys-
tems. Studies in animals have shown that hair color influences 
the incorporation ofdrugs of abuse in the general pattern of 
black hair > brown hair > blond (yellow mouse) hair(1-3). A 
study in a small number of humans has shown that codeine 
concentration in hair is dependent on melanin content (4). It 
is then reasonable to hypothesize that hair color may affect the 
interpretation f hair testing in humans. 
Hair testing isa rapidly growing technology for detecting th  
use of drugs of abuse. Several laboratories in the United States 
provide such tests (5). Their clients include Fortune 500 com- 
panies, large metropolitan police departments, Federal Reserve 
Banks, parole boards, and hundreds of high schools. One labo- 
ratory reported 750 corporate clients in 1997 and over 1700 
clients in March of 2000. Child custody services commonly 
use hair tests to detect drugs of abuse (6-8). Collection kits in 
which a hair sample can be sent to a laboratory for analysis are 
marketed to parents through pharmacies and the Internet. 
General practitioners, Medical Review Officers, and other physi- 
cians are often asked by mployers, parents, andthe courts to 
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interpret the results of hair tests for drugs of abuse. 
Federa~ guidelines that include cutoff concentrations estab- 
lishing the criteria for determining a positive from a negative 
hair sample have b en proposed (9). In the United States, a h ir 
sample is considered positive if the hair concentration f drug 
is greater than or equal to the cutoff concentration. It is pos- 
sible that, even if identical drug doses are ingested, one person 
may incorporate more drug into his/her hair than another 
person and the determination f a positive from a negative 
hair test for that drug be influenced by hair color. Prior to pro- 
mulgation of the widespread use of hair testing, a thorough un- 
derstanding of the factors such as hair color that might 
influence the interpretation f results is necessary. 
Urine drug tests are routinely used to detect the use of drugs 
of abuse. As an adjunct to urine tests, hair tests are noninvasive 
and have the potential to increase the window of detection of 
drug long after the drug has been eliminated from the rest of 
the body. Because of this unique sensitivity, it is critical to de- 
termine whether all subjects ingesting similar amounts of 
drugs of abuse have similar amounts in their hair, and if not, to 
understand why. An effect ofhair color on the interpretation of 
hair tests for drugs of abuse will have profound social and cul- 
tural implications to thousands of persons undergoing hair 
tests annually. Understanding the scientific basis for such an ef- 
fect will increase the credibility of a potentially usefat test o de- 
tect the use of drugs of abuse. 
To determine the role of hair color on drug incorporation, we 
administered identical doses of codeine to healthy human vol- 
unteers who had either ed, blond, brown, or black hair. Black- 
haired subjects included Caucasians and non-Caucasians. The 
codeine concentrations were measured in hair collected for 
seven weeks after drug administration. The quantitative and 
qualitative melanin profiles were determined for each subject's 
hair to provide an objective measure of hair color. The plasma 
concentrations of codeine were measured to eliminate differ- 
ences in the bioavai~ability and clearance of codeine as factors 
that might account for the differences in codeine hair concen- 
trations. 
Methods 
Protocol 
We studied 44 healthy male (n = 24) and female (n = 20) vol- 
unteers (ages 21--40 years) with black, brown, blond, or red hair. 
The subjects serf-reported th ir race. The study was approved by 
the human studies committee ofthe University of Utah Health 
Sciences Center. All subjects gave written informed consent and 
were compensated forparticipation. 
Each subject was given oral codeine phosphate syrup in a 
dosage of 30 mg three times a day for five days. Twenty-four 
hours after the end of the treatment period, a 30-rag codeine 
dose was administered, and the subject's plasma area under the 
concentration time curve (AUC) for codeine was determined. 
Blood for AUC determination was collected at 0, 0.5, 1, 2, 4, 6, 
8, 12, and 24 h after the single codeine dose. The subjects were 
asked not to cut their hair in the vertex region of the scalp or 
use any form of chemical treatment on their hair, but to use 
normal hygienic measures othe~ise. Hair was collected by 
cutting approximately 50-100 hairs from the vertex region of 
the scalp immediately prior to dosing and at weeks 1, 4, 5, 6, 
and 7 after dosing. Hair was cut within 2 mm of the scalp. 
Hair was stored at -20~ in aluminum foil and oriented so 
that the scalp end could be identified. Prior to analysis, indi- 
vidual hair were aligned and the proximal (closest to scalp) 3 cm 
for each hair was identified, trimmed from the remainder ofthe 
hair, and used for analysis of codeine. 
Analysis of codeine 
Hair. After adding deuterated codeine (2H3-codeine, 7.5 
ng/mg) as an internal standard to 20 mg of hair, the sample was 
solubilized with NaOH and extracted with n-butyl chloride/ace- 
tonitrile (4:1, v/v). An aliquot of the extract was analyzed on a 
high-performance liquid chromatograph-mass selective de- 
tector (1100 LC-MSD; Hewlett-Packard, Palo Alto, C ) in the 
electrospray (API-ES) positive ion mode using an ODS-AQ C18 
S-5 column (50 m x 2.0-ram i.d., 120.~ particle size, YMC, Inc., 
Wilmington, NC). The mobile phase was a mixture of water, 
0.1% acetic acid, and methanol. The limit of quantitation (LOQ) 
of codeine in hair was 20 pg/mg hair (10). The coefficients of 
variation for intra-assay nd interassay precision were less than 
7% at codeine concentrations of 6.05, 0.3, and 5 ng/mg hair 
(11). At hese same concentrations, the accuracy of the assay 
was within 10% of the target values with coefficients of varia- 
tion of less than 7%. 
Morphine, a metabolite ofcodeine, was not measured inthis 
study because in a previous tudy with this dosage regimen, 
morphine was not detected in the hair (12). Hair was not 
washed in the laboratory prior to analysis for codeine. Pre- 
vious research in our laboratory has shown that laboratory 
washing of hair can remove drug that has been i corporated 
into the hair via the circulation (13). It was unlikely that there 
would be external exposure to codeine from smoke or !~owder 
during the study time periods, and we did not want the poten- 
tial removal of incorporated codeine to influence our results. 
Plasma. Codeine quantitation i plasma (1 mL) was per- 
formed by GC-MS (El, SIM mode, HP 5973) equipped with an 
HP-5MS column (30 m x 0.25-mm i.d., 0.25-1Jm film thickness) 
using deuterated co eine as an internal standard. Liquid-liquid 
extraction was performed with 2 mL buffer composed of a sat- 
urated solution of ammonium chloride in ammonium hy- 
droxide (pH 9.5) and 3 mL chloroform/isopropanol (9:1, v/v). 
The sample was derivatized with 2,2,3,3,3-pentafluoro-1- 
propanol (PFP-OH, 70 IJL, Regis Technology, inc., Morton 
Grove, IL) and pentafluoropropionic anhydride (PFPA, 100 laL, 
Regis Technology, Inc.) for 30 rain at 70~ The LOQ, esti- 
mated by the signal-to-noise ratio method, was 2 ng/mL. 
Analysis of melanin 
Eumelanin. The degradation products pyrrole-2,3 dicar- 
boxylic acid (PDCA) and pyrrole-2,3,5-tricarboxylic acid (PTCA) 
of eumelanin were measured by a modification ofthe method 
of Ito and Wakamatsu (14). Hair (5 rag) was cut into 1-2-ram 
pieces and degraded in 0.5M NaOH in 80 IJL of 3% HzO2 that 
was heated in a boiling water bath for 20 min. Phthalic acid 
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(40 nmol) was added as an internal standard prior to degrada- 
tion. Quantitation of PDCA, PTCA, and internal standard was 
carried out with a Waters 600E (Milford, MA) high-pressure 
liquid chromatography (HPLC) system with UV detection at 280 
nm. Peak-height ratios of PDCA and PTCA to internal standard 
were compared to a standard curve made from pure PDCA and 
PTCA standards subjected to alkaline hydrogen peroxide degra- 
dation. 
Pheomelanin. Hair (5 mg) was degraded with hydriodic acid 
and hypophosphorous acidin a 130~ oil bath for 16 h, and the 
degradation products 4-amino-3-hydroxyphenylalanine (AHP) 
and 3-aminotyrosine (3-AT) were measured by the method of 
K~lb et al. (15). Prior to degradation, an internal standard, 
L-cc-methylDOPA (20 nmol), was added. The degradation prod- 
ucts and internal standard were measured by HPLC with elec- 
trochemical detection (+400 mV relative to a silver-silver 
chloride reference electrode). Thepeak-height ratios of AHP 
and 3-AT to internal standard were compared to a standard 
curve made from pure AHP and 3-AT standards subjected to 
hydriodic acid degradation. 
Statistical analysis 
The data reported escribe the total available study popula- 
tion. Means and standard errors of the mean (SE) are pre- 
sented for different categories (i.e., hair color, race, and week of 
hair collection) and variables (i.e., codeine hair concentration, 
codeine AUC, eumelanin hair concentration, pheomelanin hair 
concentration, and total melanin hair concentration). Differ- 
ences between group means were analyzed using fixed-factor, 
one-way analysis of variance (Microsoft Excel Office 98,Red- 
mond, WA) for hair color and race. Comparisons among roups 
were considered statistically significant at p _< 0.05. For each 
category, comparisons between groups (i.e., black hair vs. blond 
hair) were performed using an unpaired t-test for independent 
samples. Comparison of variances at the 0.025 level ofsignifi- 
cance was used to test for homogeneity of the variance. The 
assumptions ofnormality and homogeneity of variance were 
met for all comparisons. 
Table I. Hair Color, Reported Race, and Area Under the 
Plasma Codeine Time Curve for Study Subjects 
Plasma 
Hair Codeine AUC 
Color Race n Male Female h-ng/mL* 
Black African American 2 2 0 127.7 
American Indian I 1 0 296.4 
Hispanic 2 2 0 198.1 
Asian 5 1 4 299.5 + 58.8 t 
Caucasian 6 3 3 166.1 + 14.6 
Total 16 
Brown Caucasian 12 6 6 209.3 • 17.1 
Blond Caucasian 8 6 2 177.9 • 19.7 
Red Caucasian 6 2 4 250.5 • 32.6 
* Data are presented as mean + SE. Plasma AUC was determined after a 
single 30-rag oral dose of codeine. 
4- Different from Caucasians with black hair (p = 0.085). 
Results 
The data from one African-American subject were dropped 
from the study because codeine wa~ found in his predose hair 
(800 pg/mg), and he admitted taking codeine prior to the study. 
The data from one Asian subject were dropped because he did 
not complete the study. There were no significant differences 
(p < 0.05) in the codeine plasma AUC for any group of subjects 
(Table I). The difference between th  AUC for Asian subjects and 
Caucasian subjects with black hair was not significant at the 
p g 0.05 level (p = 0.085). There were no significant differ- 
ences in hair codeine concentrations or plasma AUC between 
male and female subjects in this study. 
Codeine was not detected inthe predose hair of 39 of 42 sub- 
jects; codeine was detected inthe predose hair of three subjects, 
but it contributed less than 10% of the measured concentration 
of codeine during weeks 4, 5, 6, and 7. Codeine was detected in 
hair l week after codeine administration in 15 of 42 subjects; all 
subjects were positive for codeine 4 weeks after codeine ad- 
ministration. When all subjects were compared, those with 
black hair had a 7-fold greater codeine concentration than 
those with brown hair and a 14-15-fold greater codeine con- 
centration than those with blond or red hair (Figure 1). Al- 
though there was a downward trend in the hair codeine 
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Figure 1. Mean codeine concentrations in the hair of all subjects with 
black hair and Caucasians with black, brown, blond, or red hair during 
weeks 4, 5, 6, and 7 after codeine administration. Error bars represent SE. 
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Figure 2. Mean codeine concentrations in the hair of Asian and Cau- 
casian subjects during weeks 4, 5, 6, and 7 after codeine administration. 
Error bars represent SE. 
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concentrations between weeks 4 and 7 for all hair colors, there 
were no significant differences in the hair codeine concentra- 
tions for subjects with any hair color between weeks 4, 5, 6, or 
7 after codeine administration. When the hair codeine concen- 
trations of only Caucasian subjects were analyzed, there was still 
a 4-5-fold greater concentration i black hair than in brown 
hair and an 8-10-fold greater concentration i  black hair than 
in blond or red hair. 
Among subjects with black hair, a statistical nalysis was pos- 
sible only between Asian and Caucasian subjects because of the 
limited number of Mrican-American, American-Indian, and 
Hispanic subjects. Asian subjects with black hair had a 2.5-fold 
greater hair codeine concentration than did Caucasian sub- 
jects with black hair (Figure 2). 
The mean eumelanin, pheomelanin, and total melanin con- 
Table U. Hair Color, Reported Race, and Melanin 
Concentrations in Study Subjects* 
Total 
Hair Eumelanin Pheomelanin Melanin 
Color Pace n (Fg/mg) (pg/mg) (pg/mg) 
Black African 2 13,50 0.10 ]3.60 
American 
American 1 14.70 0,10 14.80 
Indian 
Hispanic 2 10.00 0.10 10.10 
Asian 5 11.60 • 1.83' 0.10 • 0.01 11.69 • 1.85' 
Caucasian 6 7.00 • 0.90* 0.14 • 0.04 7.11 • 0.89* 
Brown Caucasian 12 3.50• 0.11 • 3.57• 
Blond Caucasian 8 2.30• 0.11 • 2~33• 
Red Caucasian 6 1.70• 0.30 0.96 • 0.20'* 2.62 • 0.44 
*Data are presented as mean • SE. 
~ Significant differences at p _< 0.05 were observed bep~s.reen Asians and all olher 
groups. 
' Significant differences at p <_ 0.05 ','.'ere observed between Caucasians with black 
hair and Caucasians with brown, blond, or red hair. 
Significant differences at p _< 0r05 were observed between Caucasians with 
brown hair and Caucasians ;vith blond or red hair. 
' Significant differences at p -< 0.05 were observed between Caucasians with 
blond hair or red hair. 
" Significant differences at p _< 0.05 were observed between Caucasians with red 
hair and all other g oups. 
'] 
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Figure 3. Correlation between codeine concentration in the hair of all 
subjects during week 5 after codeine administration and the total melanin 
concentration. 
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centrations in the hair of each group of subjects are shown in 
Table II. The pigment in blond, brown, or black hair is com- 
posed of 95-99% eumelanin; pheomelanin contributes little to 
the total melanin content of blond, brown, or black hair. Asian 
black hair has a significantly greater eumelanin concentration 
than Caucasian black hair. Among Caucasians, there is a sig- 
nificantly lower total melanin concentration i subjects with 
brown, blond, or red hair than in subjects with black hair. The 
pheomelanin concentration is greatest in subjects with red 
hair. Among Caucasians with black, brown, blond, or red hair, 
there is an increasing contribution of pheomelanin to the total 
melanin concentration of 1.9%, 3.1%, 4.1%, and 36.6%, re- 
spectively. 
These data suggest a direct relationship between the melanin 
concentration a d the concentration of codeine in hair. When 
analyzed, a positive relationship was observed (/?~ = 0.73, p < 
0.001) for the comparison of the log of the week 5 hair codeine 
concentration for each subject and the total melanin concen- 
tration (Figure 3). The positive y-intercept suggests that even if 
hair contained no melanin, a small amount of codeine would 
still be incorporated. 
Cutoff concentrations are frequently used by drug-testing 
laboratories todetermine a positive from a negative specimen. 
A specimen drug concentration equal to or greater than the 
cutoff would be reported as positive. A specimen drug concen- 
tration less than the cutoff would be reported as negative. 
Figure 4 shows the percentage of our subjects that would be re- 
ported positive at various cutoff concentrations. Only at a cutoff 
of 50 pg/mg would all subjects be reported as positive. At a 
cutoff concentration of 500 pg/mg, only subjects with black 
hair would be positive and all subjects with brown, blond, or red 
hair would be negative. Even at a cutoff concentration f 3000 
pg/mg, 6% of subjects with black hair would still be positive. 
Discussion 
These data clearly show that codeine is incorporated into 
black hair more readily than brown hair, blond hair, or red 
hair. Therefore, it is possible that hair color may affect the 
& 
a. 
|r  COlOr 
Cutoff concentration 30~ 
(pg/mg hair) 
Figure 4. Percentage of subjects with various hair colors who would be 
reported as positive for codeine at different cutoff" concentrations. 
548 
Journal of Analytical Toxicology, Vol. 27, November~December 2003 
interpretation of hair codeine concentrations (at least after he 
doses used in this study). If the proposed federal guidelines are 
enacted, the suggested codeine cutoff of200 pg/mg would result 
in 100% of subjects with black hair and 50% of subjects with 
brown hair being reported as positive, and osubjects with 
blond or red hair being reported as negative for codeine. Wennig 
(16) has proposed a cutoff of 500 pg/mg for opiates in hair. At 
this cutoff concentration, 100% of subjects with red, blond, or 
brown hair would be negative, whereas 80% ofpersons with 
black hair would still be positive. Raising the codeine cutoff to 
1000 pg/mg or 3000 pg/mg would not totally eliminate the hair 
color effect for codeine. 
The dose of codeine used in this study, although igh, is 
likely to be prescribed for patients after surgery or trauma. 
Thus, it is possible that following a therapeutic dose of codeine, 
a person with black hair would be reported positive for the 
abuse of codeine based ona hair test; a person with red, blond, 
or brown hair would likely be r ported negative. The dose pro- 
portionality in the hair concentration f codeine would lead to 
the conclusion that, even after a single codeine dose, persons 
with black hair could have a positive hair test for codeine 
(12,17). 
Hair color results from melanin, which is synthesized in
melanocytes within the hair bulb, being deposited nto ker- 
atinocytes that mature into the hair shaft (18). Melanin is a 
polyanionic polymer consisting of eumelanin, which is re- 
sponsible for black and brown hair color, and pheomelanin, 
which is responsible for red hair color. Eumelanin is a polymer 
composed primarily of subunits of 5,6-dihydroxyindole and5,6- 
dihydroxindole-2-carboxylic acid. Pheomelanin s a polymer 
composed of benzothiazine subunits derived from cysteinyl- 
dopa (19). The quantity and type of melanins incorporated into
hair from elanocytes are genetically controlled. 
In careful analyses of hair testing results from commercial 
laboratories, several studies found no significant association 
between hair color or race and analyte detected in the hair 
(20-22). The most likely explanations for thedifference be- 
tween our study and these population studies are that in the 
population studies: (1) cocaine, rather than codeine, was the 
most common drug studied, (2) there is no accurate way of 
knowing the dose of drug ingested, and (3) there was no objec- 
tive measure of hair color. The dose of codeine in our study was 
carefully controlled. This does not negate the importance of
population studies, butdoes suggest that dose must be carefully 
considered when evaluating the factors that affect drug incor- 
poration into hair. 
Studies of limited scope have demonstrated an effect of hair 
pigment on drug incorporation (4,23,24), and one study has 
suggested that there is a racial bias in the interpretation f 
hair tests for cocaine (25). Kmnstrand et al. (4), in a study of 
nine subjects with mostly light colored hair, have shown that 
the codeine concentration i  hair is dependent on melanin 
content; hey have reported similar findings for incorporation 
of selegiline metabolites in hair from 10 subjects (26). Cone and 
Joseph (27) have presented a strong case for the potential for a 
hair color effect on testing for drugs of abuse. The in vitro 
binding of codeine to hair has been shown tocorrelate well with 
its in vivo incorporation (3). The mechanism for codeine 
binding to melanin in hair is not completely understood. 
Melanin is polyanionic (28), whereas codeine, as a weak base, is 
cationic at physiological pH. Nakahara et al.(29) has demon- 
strated a correlation between drug basicity, melanin binding, 
and drug incorporation i to rat hair. The importance of basicity 
is exemplified by experiments tha  how that the weak acid 
phenobarbital does not preferentially incorporate into pig- 
mented hair (30). These findings lead to the hypothesis that a 
strong ionic bond forms between melanin and weak bases such 
as codeine and that his does not occur with weak acids such as 
phenobarbital. Many drugs of abuse, including opiates, cocaine, 
amphetamines, and phencyclidine, are weak bases, and their in- 
corporation i to hair would likely show a correlation with 
melanin concentration similar to what we have found for 
codeine. 
We report a positive relationship between h  codeine con- 
centration and the total melanin concentration in hair. In non- 
Caucasian black hair the predominant pigment iseumelanin; 
pheomelanin comprises less than 1% (Asians = 0.8%) of the 
total melanin content. Caucasians with black hair have a total 
melanin content in hair that is significantly lower than non- 
Caucasians (Asians) and the percentage ofthe total melanin 
that is pheomelanin is greater (1.9%). The percentage of total 
melanin that is pheomelanin in Caucasians with brown, blond, 
or red hair is 3.1%, 4.1%, and 36.6%, respectively. Binding of 
drugs to eumelanin has been reported extensively (28,31), but 
there are few reports of drug binding to pheomelanin (32). We 
also found a positive correlation between h  hair codeine con- 
centration and the eumelanin concentration r the ratio of 
pheomelanin to eumelanin (data not shown). The precise role 
that pheomelanin plays in incorporating drugs of abuse into hair 
is unknown. In addition, there appear to be factors other than 
melanin that contribute to the incorporation ofcodeine into 
hair. The positive y-intercept inFigure 3 suggests hat persons 
with no melanin would still incorporate a small amount of 
codeine into their hair. In previous studies conducted in animals 
with white hair that contains no measurable melanin, drugs of 
abuse, including codeine, were still incorporated (1,3). Thus, al- 
though melanin is a strong factor in determining the hair con- 
centration of some drugs, it appears not to be the only factor. 
Codeine was found in the hair of all subjects 4, 5 6, and 7 
weeks after oral administration f a therapeutic dose. Although 
there was a trend for the codeine concentrations to decrease 
from week 4 to week 7, there was no significant change in the 
hair codeine concentration during the course of the study. The 
binding of codeine to structural or chemical components of hair 
does not appear to be substantially disrupted by normal hygienic 
procedures. Chemical treatment (i.e., coloration) of the hair has 
been reported to affect drug concentrations (33); no subject in 
this study performed chemical treatment ofhis/her hair during 
the study period. The lower limit of quantitation f codeine in 
our assay was 20 pg/mg of hair. It is probable that after the ad- 
ministration of codeine in a therapeutic dose, persons with 
black hair would have detectable codeine in th ir hair for sub- 
stantially longer than 7 weeks, long after there is no codeine in 
their plasma. This demonstrates he long window of detection 
of drugs in hair. 
The observed difference in codeine hair concentrations be- 
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tween Asians and Caucasians with black hair is likely due to sev- 
eral factors. Asians in this study have a higher total melanin 
concentration in their hair than do Caucasians. Asians have  
reported deficiency of CYP 2D6, which is responsible for the 
demethylation of codeine to morphine (34). This may con- 
tribute to the greater (although not statistically significant) 
plasma AUC in Asians and the significantly higher concentra- 
tions of codeine observed in Asian hair in our study. In addition, 
there might be inherent differences in the physical structure of
Asian hair that facilitates he incorporation of codeine. 
The correlation between the hair codeine and melanin con- 
centrations suggests the possibility that the codeine concentra- 
tion could be normalized forthe hair color effect by expressing 
it as a function ofthe melanin concentration rather than by hair 
weight. Normalization reduced the difference between Cau- 
casian subjects with black hair and subjects with brown hair 
from 4-5-fold to less than 2-fold; after normalization, there 
were no significant differences in the hair codeine concentration 
between subjects with brown, blond, or red hair. The normalized 
mean codeine concentrations in Caucasians with black, brown, 
blond, or ed hair were 100.5, 60.5, 42.3, and 40.9 pg/pg melanin, 
respectively. Asians with black hair had a normalized mean 
codeine concentration of 251.8 pg/pg melanin. It is probable that 
the hair concentration of other drugs of abuse that are weak 
bases uch as cocaine, morphine, amphetamines, and phency- 
clidine could also be normalized in this way. 
These data clearly show that e interpretation of hair tests for 
codeine are influenced by the color of a person's hair. By nor- 
malizing the drug concentration with the measured melanin 
concentration it may be possible to substantially reduce this in- 
fluence. Our data do not address the issue of whether the ex- 
ternal deposition ofdrugs onto hair, such as by smoke, is also 
affected by hair pigmentation. Although our study involved 
only the incorporation of codeine into hair, it is probable, based 
on experiments in animals, that other drugs of abuse such as co- 
caine, phencyclidine, and amphetamines will follow a similar 
pattern. The incorporation f these drugs into hair should be 
studied carefully in humans to ensure the appropriate inter- 
pretation of drug concentrations. 
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